中文簡(jiǎn)介

我們已經(jīng)看到并將繼續(xù)看到腫瘤學(xué)領(lǐng)域的巨大變化。雖然疾病負(fù)擔(dān)將增加，但腫瘤學(xué)家可用的醫(yī)療設(shè)備將更大、更堅(jiān)固，并有可能專(zhuān)注于個(gè)人需求。未來(lái)腫瘤學(xué)（ISSN1479-6694）為癌癥治療的新時(shí)代提供了一個(gè)論壇。該雜志關(guān)注最重要的進(jìn)展，并強(qiáng)調(diào)其在臨床環(huán)境中的相關(guān)性。此外，未來(lái)腫瘤學(xué)以簡(jiǎn)潔、一目了然的文章格式提供基本信息，這對(duì)于向時(shí)間日益有限的社區(qū)提供信息至關(guān)重要。該雜志對(duì)科學(xué)和臨床問(wèn)題，以及經(jīng)濟(jì)、政策和現(xiàn)實(shí)世界問(wèn)題采取了前瞻性的立場(chǎng)，我們?cè)谶@個(gè)癌癥治療的新時(shí)代所面臨的問(wèn)題。該雜志包括文獻(xiàn)意識(shí)，如放射治療和免疫治療的最新進(jìn)展，簡(jiǎn)明的評(píng)論和分析，以及全面的評(píng)論文章，所有這些都提供了關(guān)鍵的發(fā)現(xiàn)，轉(zhuǎn)化為臨床環(huán)境。討論的主題包括：新型抗癌劑概況正在進(jìn)行的研究的方案選擇性和“個(gè)性化”方法新免疫療法、放射療法和生物標(biāo)志物的臨床意義和應(yīng)用診斷和治療方法的整合分子遺傳學(xué)對(duì)預(yù)防、篩選、診斷和治療的影響篩選方案和方法癌癥的生物學(xué)過(guò)程以及新的認(rèn)識(shí)將如何影響治療關(guān)于政策和治療指南的當(dāng)前辯論現(xiàn)實(shí)數(shù)據(jù)和結(jié)果研究該雜志歡迎不請(qǐng)自來(lái)的文章建議。

投稿網(wǎng)址：http://www.futuremedicine.com/page/submitarticle

英文簡(jiǎn)介

We have seen and will continue to see dramatic changes within the field of oncology. Whilst the burden of disease is set to increase, the available armamentarium to the oncologist will be greater, more robust and offer the potential to focus on individual needs. Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic, policy and real world issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting. Topics addressed include:Profiles of new anticancer agentsProtocols of on-going studies Selective and 'personalized' approachesClinical implications and applications for new immunotherapies, radiotherapies and biomarkersIntegration of diagnostic and therapeutic approachesImpact of molecular genetics on prevention, screening, diagnosis and treatmentScreening programs and methodologyBiological processes involved in cancer and how new understanding will impact treatmentCurrent debates on policy and treatment guidelinesReal world data and outcomes research The journal welcomes unsolicited article proposals.